Fineline Cube

Follow:
14435 Articles
Policy / Regulatory

China’s Dental Implant VBP Tender Results in Significant Price Cuts

CompanyDrug

Takeda’s Mobocertinib Approved in China for EGFR Exon20ins NSCLC

CompanyDeals

MediTrust Health Secures Series C+ Funding with HSBC as Strategic Investor

CompanyDrug

Kelun-Biotech’s SKB264 Approved for Phase II Study in EGFR-Mutant NSCLC

Company

BeiGene Outlines Global R&D Strategy at J.P. Morgan Healthcare Summit

CompanyDeals

Evopoint Biosciences Licenses SOS1 Inhibitor to METiS Therapeutics

CompanyDrug

Pfizer’s Nurtec ODT Launches in China via Hainan’s Bo’Ao Lecheng Zone

CompanyDeals

HKEX 2022 Annual Report: IPO Activity Declines Amid Global Challenges

CompanyDrug

Konruns Initiates Phase II Study for KC1036 in Advanced Thymic Tumors

CompanyDrug

Dizal’s Sunvozertinib NDA Accepted for Review by China’s NMPA

CompanyDrug

HighTide Therapeutics Doses First Patient in Phase IIb Study for HTD1801 in NASH

Drug

MSD Submits Initial Quotation for Molnupiravir in China Amid New COVID-19 Rules